In addition to a recent study directly demonstrated that STING activation contributes to tumor growth [108], there are also many previous studies found that systemic treatment with DNA-containing nanoparticles stimulates IDO activity in many mouse tissues due to STING activation in innate immune cells [116], which activates Tregs and suppresses the T cell responses [117]. The gene discussed is IDO1; the disease is neoplasm.